Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Allakos | 118 | 2023q3 | |||||||||
BrainStorm Cell Therapeut... | 21 | 2021 | |||||||||
Bellerophon Therapeutics | 1 | 2021 | |||||||||
Vor Biopharma | 131 | 2023q3 | |||||||||
Karuna Therapeutics | 12,444 | 2023q3 | |||||||||
Solid Biosciences | 277 | 2023q3 | |||||||||
Palo Alto Networks | 85,700 | 2023 | |||||||||
Digital World Acquisition... | 1,373 | 2023q3 | |||||||||
Corbus Pharmaceuticals Ho... | 155 | 2023q3 | |||||||||
NeuBase Therapeutics | 34 | 2022 | |||||||||
Citius Pharmaceuticals | 125 | 2023q3 | |||||||||
Rocket Pharmaceuticals | 2,453 | 2023q3 | |||||||||
Gamida Cell | 23 | 2021 | |||||||||
Galera Therapeutics | 6 | 2021 | |||||||||
Ocugen | 299 | 2022 | |||||||||
QuantumScape | 2,585 | 2023q3 | |||||||||
Nikola Corp. | 274 | 2021 | |||||||||
Check-Cap | 195 | 2021 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Telo Genomics | 6 | 2022 |